Peter Bühlmayer

Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT₁‐receptor subtype

Leoluca Criscione, Marc de Gasparo, Peter Bühlmayer et al. · British Journal of Pharmacology · 1993 · 251 citations · Full text

Molecular Pharmacology, Molecular Physiology, Nonpeptide Antagonist +15

Valsartan: Preclinical and Clinical Profile of an Antihypertensive Angiotensin‐II Antagonist

Leoluca Criscione, William A. Bradley, Peter Bühlmayer et al. · Cardiovascular Drug Reviews · 1995 · 132 citations

Molecular Pharmacology, Hypertension, Antihypertensive Therapy +7

Pharmacokinetics, disposition and biotransformation of [14C]-radiolabelled valsartan in healthy male volunteers after a single oral dose

Felix Waldmeier, Gérard Flesch, P. Mu ̈ller et al. · Xenobiotica · 1997 · 131 citations

Plasma Radioactivity, Low Radioactivity Levels, Pharmacotherapy +16

Synthesis and biological activity of some transition-state inhibitors of human renin

Peter Bühlmayer, Walter Fuhrer, Richard Göschke et al. · Journal of Medicinal Chemistry · 1988 · 111 citations · Full text

Valsartan, a potent, orally active angiotensin II antagonist developed from the structurally new amino acid series

Peter Bühlmayer, Pascual Furet, Leoluca Criscione et al. · Bioorganic & Medicinal Chemistry Letters · 1994 · 105 citations

Medicinal Chemistry, Vascular Pharmacology, Pharmacology +4